Genpact Limited Stock Performance

G Stock  USD 31.59  0.70  2.27%   
The company retains a Market Volatility (i.e., Beta) of 1.15, which attests to a somewhat significant risk relative to the market. Genpact returns are very sensitive to returns on the market. As the market goes up or down, Genpact is expected to follow. Genpact Limited has an expected return of -0.19%. Please make sure to check out Genpact maximum drawdown, daily balance of power, period momentum indicator, as well as the relationship between the skewness and day typical price , to decide if Genpact Limited performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genpact Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's technical and fundamental indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders. ...more

Actual Historical Performance (%)

One Day Return
2.27
Five Day Return
(0.09)
Year To Date Return
(9.17)
Ten Year Return
84.41
All Time Return
88.6
Forward Dividend Yield
0.0193
Payout Ratio
0.1896
Forward Dividend Rate
0.61
Dividend Date
2024-03-26
Ex Dividend Date
2024-03-08
1
Zacks Research Equities Analysts Reduce Earnings Estimates for Genpact Limited - MarketBeat
01/25/2024
2
Disposition of 1845 shares by Donald Klunk of Genpact at 36.2656 subject to Rule 16b-3
02/15/2024
3
These 4 Measures Indicate That Genpact Is Using Debt Safely
02/29/2024
 
Genpact dividend paid on 11th of March 2024
03/11/2024
4
Genpact Named a Leader in Financial Crime and Compliance by Everest Group for Fourth Consecutive Year
03/13/2024
5
Acquisition by Donald Klunk of 3699 shares of Genpact subject to Rule 16b-3
03/15/2024
6
Acquisition by N Tyagarajan of 50000 shares of Genpact at 19.35 subject to Rule 16b-3
03/20/2024
 
Genpact dividend paid on 26th of March 2024
03/26/2024
7
Genpact Limited Shares Sold by Pacer Advisors Inc. - Defense World
04/01/2024
8
Is Genpact Limited Potentially Undervalued
04/04/2024
9
Acquisition by Ajay Agrawal of 4916 shares of Genpact subject to Rule 16b-3
04/05/2024
10
Q3 2025 Earnings Estimate for Genpact Limited Issued By Zacks Research - MarketBeat
04/09/2024
11
Genpacts CEO BK Kalra Joins Catalyst CEO Champions For Change
04/12/2024
12
Sequoia Financial Advisors LLC Buys 1671 Shares of Genpact Limited - Defense World
04/16/2024
13
The Return Trends At Genpact Look Promising
04/19/2024
Begin Period Cash Flow646.8 M
  

Genpact Relative Risk vs. Return Landscape

If you would invest  3,602  in Genpact Limited on January 22, 2024 and sell it today you would lose (443.00) from holding Genpact Limited or give up 12.3% of portfolio value over 90 days. Genpact Limited is generating negative expected returns and assumes 1.4231% volatility on return distribution over the 90 days horizon. Put is differently, 12% of stocks are less volatile than Genpact, and over 99% of all traded equities are expected to make higher returns on investment over the next 90 days.
  Expected Return   
       Risk  
Taking into account the 90-day investment horizon Genpact is expected to under-perform the market. In addition to that, the company is 2.32 times more volatile than its market benchmark. It trades about -0.14 of its total potential returns per unit of risk. The NYSE Composite is currently generating roughly 0.1 per unit of volatility.

Genpact Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Genpact's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Genpact Limited, and traders can use it to determine the average amount a Genpact's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.1369

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsG

Estimated Market Risk

 1.42
  actual daily
12
88% of assets are more volatile

Expected Return

 -0.19
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.14
  actual daily
0
Most of other assets perform better
Based on monthly moving average Genpact is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Genpact by adding Genpact to a well-diversified portfolio.

Genpact Fundamentals Growth

Genpact Stock prices reflect investors' perceptions of the future prospects and financial health of Genpact, and Genpact fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Genpact Stock performance.

About Genpact Performance

To evaluate Genpact Limited Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Genpact generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Genpact Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Genpact Limited market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Genpact's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 0.00000013  0.00 
Return On Tangible Assets 0.21  0.22 
Return On Capital Employed 0.18  0.1 
Return On Assets 0.13  0.14 
Return On Equity 0.28  0.29 

Things to note about Genpact Limited performance evaluation

Checking the ongoing alerts about Genpact for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Genpact Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Genpact Limited generated a negative expected return over the last 90 days
Genpact Limited is unlikely to experience financial distress in the next 2 years
Over 99.0% of the company shares are owned by institutional investors
On 26th of March 2024 Genpact paid $ 0.1525 per share dividend to its current shareholders
Latest headline from simplywall.st: The Return Trends At Genpact Look Promising
Evaluating Genpact's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Genpact's stock performance include:
  • Analyzing Genpact's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Genpact's stock is overvalued or undervalued compared to its peers.
  • Examining Genpact's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Genpact's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Genpact's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Genpact's stock. These opinions can provide insight into Genpact's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Genpact's stock performance is not an exact science, and many factors can impact Genpact's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether Genpact Limited is a strong investment it is important to analyze Genpact's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Genpact's future performance. For an informed investment choice regarding Genpact Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genpact Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the Genpact Limited information on this page should be used as a complementary analysis to other Genpact's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for Genpact Stock analysis

When running Genpact's price analysis, check to measure Genpact's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genpact is operating at the current time. Most of Genpact's value examination focuses on studying past and present price action to predict the probability of Genpact's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genpact's price. Additionally, you may evaluate how the addition of Genpact to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Is Genpact's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genpact. If investors know Genpact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genpact listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
2.311
Dividend Share
0.55
Earnings Share
3.41
Revenue Per Share
24.552
Quarterly Revenue Growth
0.04
The market value of Genpact Limited is measured differently than its book value, which is the value of Genpact that is recorded on the company's balance sheet. Investors also form their own opinion of Genpact's value that differs from its market value or its book value, called intrinsic value, which is Genpact's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genpact's market value can be influenced by many factors that don't directly affect Genpact's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genpact's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genpact is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genpact's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.